Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-9 of  9 results for ""Proprotein Convertases""

Your Filters

Publication : jama
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.

Subjects: COST effectiveness; PROPROTEIN convertases; SUBTILISIN inhibitors

  • Source: JAMA: Journal of the American Medical Association. 8/22/2017, Vol. 318 Issue 8, p748-750. 3p. 2 Charts.

Record details

Read More Add to Saved list
×
Academic Journal

PCSK9 Inhibitors for Statin Intolerance?

Subjects: *PROPROTEIN convertases; *STATINS (Cardiovascular agents); *DRUG dosage

  • Source: JAMA: Journal of the American Medical Association. 4/19/2016, Vol. 315 Issue 15, p1571-1572. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Trials Update.

Subjects: CLINICAL trials; PROPROTEIN convertases; THERAPEUTIC use of vitamin E

  • Source: JAMA: Journal of the American Medical Association. 5/23/2017, Vol. 317 Issue 20, p2054-2054. 1p. 1 Color Photograph.

Record details

Read More Add to Saved list
×
Academic Journal

Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.

Subjects: PROPROTEIN convertases; CARDIOVASCULAR diseases risk factors; PEOPLE with diabetes

  • Source: JAMA: Journal of the American Medical Association. 11/28/2017, Vol. 318 Issue 20, p1968-1968. 1p. 1 Color Photograph.

Record details

Read More Add to Saved list
×
Academic Journal

Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis.

Subjects: *ATHEROSCLEROSIS; *INTRAVASCULAR ultrasonography; *PROPROTEIN convertases

  • Source: JAMA: Journal of the American Medical Association. 4/25/2017, Vol. 317 Issue 16, p1690-1691. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors.

Subjects: CARDIOVASCULAR disease prevention; LOW density lipoproteins; GLUCOSIDASE inhibitors

  • Source: JAMA: Journal of the American Medical Association; 8/1/2017, Vol. 318 Issue 5, p419-420, 2p

Record details

Read More Add to Saved list
×
Academic Journal

Cholesterol, Cardiovascular Risk, Statins, PCSK9 Inhibitors, and the Future of LDL-C Lowering.

Subjects: CHOLESTEROL; CARDIOVASCULAR diseases risk factors; STATINS (Cardiovascular agents)

  • Source: JAMA: Journal of the American Medical Association; 11/15/2016, Vol. 316 Issue 19, p1967-1968, 2p

Record details

Read More Add to Saved list
×
Academic Journal

New Drug to Lower LDL Cholesterol.

Subjects: ANTICHOLESTEREMIC agents; DRUG approval; PROPROTEIN convertases

  • Source: JAMA: Journal of the American Medical Association; 9/1/2015, Vol. 314 Issue 9, p867-867, 1/4p

Record details

Read More Add to Saved list
×
Academic Journal

LAB REPORTS.

Subjects: MEDICAL research; LIVER cells; ENZYMES

  • Source: JAMA: Journal of the American Medical Association; 9/12/2007, Vol. 298 Issue 10, p1152-1152, 1p, 1 Color Photograph

Record details

Read More Add to Saved list
×
  • 1-9 of  9 results for ""Proprotein Convertases""